Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carnosine for Peripheral Arterial Disease
NCT05371145Phase 2Recruiting
- Start
- Mar 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial. Primary endpoint: 6-Minute Walk Test at 3 months. Started Mar 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05371145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05371145.